Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology
-
Published:2023-09-27
Issue:12
Volume:97
Page:3075-3083
-
ISSN:0340-5761
-
Container-title:Archives of Toxicology
-
language:en
-
Short-container-title:Arch Toxicol
Author:
Botham Philip, Cronin Mark T. D.ORCID, Currie Richard, Doe JohnORCID, Funk-Weyer Dorothee, Gant Timothy W.ORCID, Leist MarcelORCID, Marty SueORCID, van Ravenzwaay BennardORCID, Westmoreland Carl
Abstract
AbstractIn Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) the criterion for deciding the studies that must be performed is the annual tonnage of the chemical manufactured or imported into the EU. The annual tonnage may be considered as a surrogate for levels of human exposure but this does not take into account the physico-chemical properties and use patterns that determine exposure. Chemicals are classified using data from REACH under areas of health concern covering effects on the skin and eye; sensitisation; acute, repeated and prolonged systemic exposure; effects on genetic material; carcinogenicity; and reproduction and development. We analysed the mandated study lists under REACH for each annual tonnage band in terms of the information they provide on each of the areas of health concern. Using the European Chemicals Agency (ECHA) REACH Registration data base of over 20,000 registered substances, we found that only 19% of registered substances have datasets on all areas of health concern. Information limited to acute exposure, sensitisation and genotoxicity was found for 62%. The analysis highlighted the shortfall of information mandated for substances in the lower tonnage bands. Deploying New Approach Methodologies (NAMs) at this lower tonnage band to assess health concerns which are currently not covered by REACH, such as repeat and extended exposure and carcinogenicity, would provide additional information and would be a way for registrants and regulators to gain experience in the use of NAMs. There are currently projects in Europe aiming to develop NAM-based assessment frameworks and they could find their first use in assessing low tonnage chemicals once confidence has been gained by their evaluation with data rich chemicals.
Funder
ECETOC DK EPA Land-BW Horizon 2020 Framework Programme National Institute of Health Research
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Reference31 articles.
1. Andersson N, Arena M, Auteri D, Barmaz S, Grignard E, Kienzler A, Lepper P, Lostia AM, Munn S, Parra Morte JM, Pellizzato F, Tarazona J, Terron A, Van der Linden S (2018) Guidance for the identification of endocrine disruptors in the context of regulations (EU) No 528/2012 and (EC) No 1107/2009. EFSA J 16:5311. https://doi.org/10.2903/j.efsa.2018.5311.ECHA-18-G-01-EN 2. Ball N, Bars R, Botham PA, Cuciureanu A, Cronin MTD, Doe JE, Dudzina T, Gant TW, Leist M, van Ravenzwaay B (2022) A framework for chemical safety assessment incorporating new approach methodologies within REACH. Arch Toxicol 96:743–766. https://doi.org/10.1007/s00204-021-03215-9 3. Baltazar M, Cable S, Carmichael P, Cubberly R, Cull T, Delagrange M, Dent M, Hatherell S, Houghton J, Kukic P, Li H, Lee M-Y, Malcomber S, Middleton A, Moxon T, Nathanail A, Nicol B, Pendlington R, Reynolds G, Reynolds J, White A, Westmoreland C (2020) A next-generation risk assessment case study for Coumarin in cosmetic products. Toxicol Sci 176:236–252. https://doi.org/10.1093/toxsci/kfaa048 4. Berggren E, Worth AP (2023) Towards a future regulatory framework for chemicals in the European Union—chemicals 20. Regul Toxicol Pharmacol 142:105431. https://doi.org/10.1016/j.yrtph.2023.105431 5. Dent MP, Vaillancourt E, Thomas RS, Carmichael PL, Ouedraogo G, Kojima H, Barroso J, Ansell J, Barton-Maclaren TS, Bennekou SH, Boekelheide K, Ezendam J, Field J, Fitzpatrick S, Hatao M, Kreiling R, Lorencini M, Mahony C, Montemayor B, Mazaro-Costa R, Oliveira J, Rogiers V, Smegal D, Taalman R, Tokura Y, Verma R, Willett C, Yang C (2021) Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients. Regul Toxicol Pharmacol 125:105026. https://doi.org/10.1016/j.yrtph.2021.105026
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|